Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Registry on the Use of the Direct Oral Anticoagulants for the Treatment of Unusual Site Venous Thromboembolism

NCT03778502 is registered in ClinicalTrials.gov with University of Malta as lead sponsor.

NCT NCT03778502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03778502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Registry on the Use of the Direct Oral Anticoagulants for the Treatment of Unusual Site Venous Thromboembolism
Lead sponsor
University of Malta
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
December 31, 2024
Enrollment
358 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vein thrombosis, ovarian vein thrombosis, renal vein thrombosis, retinal vein thrombosis, splanchnic vein thrombosis